Cargando…
Docking and Molecular Dynamic of Microalgae Compounds as Potential Inhibitors of Beta-Lactamase
Bacterial resistance is responsible for a wide variety of health problems, both in children and adults. The persistence of symptoms and infections are mainly treated with β-lactam antibiotics. The increasing resistance to those antibiotics by bacterial pathogens generated the emergence of extended-s...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836116/ https://www.ncbi.nlm.nih.gov/pubmed/35163569 http://dx.doi.org/10.3390/ijms23031630 |
_version_ | 1784649597235232768 |
---|---|
author | Pestana-Nobles, Roberto Aranguren-Díaz, Yani Machado-Sierra, Elwi Yosa, Juvenal Galan-Freyle, Nataly J. Sepulveda-Montaño, Laura X. Kuroda, Daniel G. Pacheco-Londoño, Leonardo C. |
author_facet | Pestana-Nobles, Roberto Aranguren-Díaz, Yani Machado-Sierra, Elwi Yosa, Juvenal Galan-Freyle, Nataly J. Sepulveda-Montaño, Laura X. Kuroda, Daniel G. Pacheco-Londoño, Leonardo C. |
author_sort | Pestana-Nobles, Roberto |
collection | PubMed |
description | Bacterial resistance is responsible for a wide variety of health problems, both in children and adults. The persistence of symptoms and infections are mainly treated with β-lactam antibiotics. The increasing resistance to those antibiotics by bacterial pathogens generated the emergence of extended-spectrum β-lactamases (ESBLs), an actual public health problem. This is due to rapid mutations of bacteria when exposed to antibiotics. In this case, β-lactamases are enzymes used by bacteria to hydrolyze the beta-lactam rings present in the antibiotics. Therefore, it was necessary to explore novel molecules as potential β-lactamases inhibitors to find antibacterial compounds against infection caused by ESBLs. A computational methodology based on molecular docking and molecular dynamic simulations was used to find new microalgae metabolites inhibitors of β-lactamase. Six 3D β-lactamase proteins were selected, and the molecular docking revealed that the metabolites belonging to the same structural families, such as phenylacridine (4-Ph), quercetin (Qn), and cryptophycin (Cryp), exhibit a better binding score and binding energy than commercial clinical medicine β-lactamase inhibitors, such as clavulanic acid, sulbactam, and tazobactam. These results indicate that 4-Ph, Qn, and Cryp molecules, homologous from microalgae metabolites, could be used, likely as novel β-lactamase inhibitors or as structural templates for new in-silico pharmaceutical designs, with the possibility of combatting β-lactam resistance |
format | Online Article Text |
id | pubmed-8836116 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88361162022-02-12 Docking and Molecular Dynamic of Microalgae Compounds as Potential Inhibitors of Beta-Lactamase Pestana-Nobles, Roberto Aranguren-Díaz, Yani Machado-Sierra, Elwi Yosa, Juvenal Galan-Freyle, Nataly J. Sepulveda-Montaño, Laura X. Kuroda, Daniel G. Pacheco-Londoño, Leonardo C. Int J Mol Sci Article Bacterial resistance is responsible for a wide variety of health problems, both in children and adults. The persistence of symptoms and infections are mainly treated with β-lactam antibiotics. The increasing resistance to those antibiotics by bacterial pathogens generated the emergence of extended-spectrum β-lactamases (ESBLs), an actual public health problem. This is due to rapid mutations of bacteria when exposed to antibiotics. In this case, β-lactamases are enzymes used by bacteria to hydrolyze the beta-lactam rings present in the antibiotics. Therefore, it was necessary to explore novel molecules as potential β-lactamases inhibitors to find antibacterial compounds against infection caused by ESBLs. A computational methodology based on molecular docking and molecular dynamic simulations was used to find new microalgae metabolites inhibitors of β-lactamase. Six 3D β-lactamase proteins were selected, and the molecular docking revealed that the metabolites belonging to the same structural families, such as phenylacridine (4-Ph), quercetin (Qn), and cryptophycin (Cryp), exhibit a better binding score and binding energy than commercial clinical medicine β-lactamase inhibitors, such as clavulanic acid, sulbactam, and tazobactam. These results indicate that 4-Ph, Qn, and Cryp molecules, homologous from microalgae metabolites, could be used, likely as novel β-lactamase inhibitors or as structural templates for new in-silico pharmaceutical designs, with the possibility of combatting β-lactam resistance MDPI 2022-01-31 /pmc/articles/PMC8836116/ /pubmed/35163569 http://dx.doi.org/10.3390/ijms23031630 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pestana-Nobles, Roberto Aranguren-Díaz, Yani Machado-Sierra, Elwi Yosa, Juvenal Galan-Freyle, Nataly J. Sepulveda-Montaño, Laura X. Kuroda, Daniel G. Pacheco-Londoño, Leonardo C. Docking and Molecular Dynamic of Microalgae Compounds as Potential Inhibitors of Beta-Lactamase |
title | Docking and Molecular Dynamic of Microalgae Compounds as Potential Inhibitors of Beta-Lactamase |
title_full | Docking and Molecular Dynamic of Microalgae Compounds as Potential Inhibitors of Beta-Lactamase |
title_fullStr | Docking and Molecular Dynamic of Microalgae Compounds as Potential Inhibitors of Beta-Lactamase |
title_full_unstemmed | Docking and Molecular Dynamic of Microalgae Compounds as Potential Inhibitors of Beta-Lactamase |
title_short | Docking and Molecular Dynamic of Microalgae Compounds as Potential Inhibitors of Beta-Lactamase |
title_sort | docking and molecular dynamic of microalgae compounds as potential inhibitors of beta-lactamase |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836116/ https://www.ncbi.nlm.nih.gov/pubmed/35163569 http://dx.doi.org/10.3390/ijms23031630 |
work_keys_str_mv | AT pestananoblesroberto dockingandmoleculardynamicofmicroalgaecompoundsaspotentialinhibitorsofbetalactamase AT arangurendiazyani dockingandmoleculardynamicofmicroalgaecompoundsaspotentialinhibitorsofbetalactamase AT machadosierraelwi dockingandmoleculardynamicofmicroalgaecompoundsaspotentialinhibitorsofbetalactamase AT yosajuvenal dockingandmoleculardynamicofmicroalgaecompoundsaspotentialinhibitorsofbetalactamase AT galanfreylenatalyj dockingandmoleculardynamicofmicroalgaecompoundsaspotentialinhibitorsofbetalactamase AT sepulvedamontanolaurax dockingandmoleculardynamicofmicroalgaecompoundsaspotentialinhibitorsofbetalactamase AT kurodadanielg dockingandmoleculardynamicofmicroalgaecompoundsaspotentialinhibitorsofbetalactamase AT pachecolondonoleonardoc dockingandmoleculardynamicofmicroalgaecompoundsaspotentialinhibitorsofbetalactamase |